Shilpa Medicare Ltd Board of Directors
Board of Directors at Shilpa Medicare Ltd
Independent Director
Independent Director
Independent Director
Independent Director
Chairman (Non-Executive)
Key Highlights
- Omprakash Inani continues to serve as the Chairman & Non Executive Dir. in 2026, maintaining the same position as in the previous year.
- Vishnukant Bhutada continues to serve as the ED / MD / Promoter in 2026, maintaining the same position as in the previous year.
- Hetal Gandhi continues to serve as the Independent Non Exe. Director in 2026, maintaining the same position as in the previous year.
- Sharath Reddy Kalakota continues to serve as the E D & Wholetime Director in 2026, maintaining the same position as in the previous year.
- Anita Bandyopadhyay joins the board as Independent Non Exe. Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Shilpa Medicare Ltd
NSE: SHILPAMED
Share Price
Last Ten Days Market Price
| Date | |
|---|---|
| 06 Oct 2026 | 1072.45 |
| 05 Oct 2026 | 1030.8 |
| 01 Oct 2026 | 1063.65 |
| 30 Sep 2026 | 1045.75 |
| 29 Sep 2026 | 1056.6 |
| 28 Sep 2026 | 1023.2 |
| 25 Sep 2026 | 1012.45 |
| 24 Sep 2026 | 1007.85 |
| 23 Sep 2026 | 1037.1 |
| 22 Sep 2026 | 1033.2 |
Company Fundamentals for Shilpa Medicare Ltd
Market Cap
20,975 Cr
EPS
14.5
P/E Ratio (TTM)
73.8
P/B Ratio (TTM)
8.1
Day’s High
1078.8
Day’s Low
1029.7
DTE
0.3
ROE
9.4
52 Week High
1095.65
52 Week Low
260.0
ROCE
10.7
Market Price of Shilpa Medicare Ltd
1M
1Y
3Y
5Y
Shilpa Medicare Ltd News Hub
Shilpa Medicare to conduct AGM
Shilpa Medicare announced that the 37th Annual General Meeting (AGM) of the company will be held on
Read more
16 Aug 24
Shilpa Medicare consolidated net profit rises 1091.53% in the June 2024 quarter
Net profit of Shilpa Medicare rose 1091.53% to Rs 14.06 crore in the quarter ended June 2024 as agai
Read more
08 Aug 24
Shilpa Medicare to announce Quarterly Result
Shilpa Medicare will hold a meeting of the Board of Directors of the Company on 8 August 2024. Power
Read more
02 Aug 24
Shilpa Medicare update on its CDMO customer - Unicycive Therapeutics
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) announced the submission of NDA to U.S. FDA for Oxylanth
Read more
04 Sept 24
